(Q42790616)

English

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections

scientific article published on November 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

0 references

ceftaroline fosamil

1 reference

ChEBI release 2020-05-28

2

object named as

Mark H Wilcox

0 references

author name string

G Ralph Corey

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

George H Talbot

3

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Dirk Thye

4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

David Friedland

5

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Tanya Baculik

6

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

CANVAS 1 investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

65 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

iv41-51

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Waves of resistance: Staphylococcus aureus in the antibiotic era.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Methicillin-resistant Staphylococcus aureus, Western Australia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Latin America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Invasive methicillin-resistant Staphylococcus aureus infections in the United States

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

TAK-599, a novel N-Phosphono type prodrug of anti-MRSA cephalosporin T-91825: synthesis, physicochemical and pharmacological properties

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKQ254

21 January 2018

Identifiers

10.1093/JAC/DKQ254

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42790616&oldid=2164315903"